Artificial intelligence (AI) is transforming neurological research, offering unprecedented opportunities for improving diagnosis, treatment, and management of neurological disorders. China and the USA ...

Generative Artificial Intelligence (AI) is boosting anticipatory forms of governance around the world, helping state actors ...

Insights from joining correctional leaders, policymakers, and advocates on trips to Germany and Norway to learn about more ...

European regulators have finally approved the Alzheimer’s treatment Leqembi after an advisory committee initially rejected the drug last summer.

Genetic factors are thought to play a major role in the development of autism – but for decades what they are has proven elusive. Now scientists are starting to uncover clues.

A team of over 150 scientists has achieved what once seemed impossible: a complete wiring and activity map of a tiny section ...

Researchers mapped 84,000 neurons in a mouse brain after it watched video clips. The 3D map links structure and activity.

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

From a cubic millimeter of brain tissue, scientists have constructed a precise, 3D map of the activity in a mouse’s brain, detailing 84,000 neurons and more than 500 million synapses.

The entrepreneurs and scientists of this year’s 30 Under 30 list are making inroads in traditionally underserved sectors like ...

From wearable devices to education services, these young trailblazers are solving global challenges with innovative products and platforms.

Ivana Galinovic discusses the AI-driven DORIAN GRAY project to assess, prevent and manage mild cognitive impairment in CVD.